Purdue Pharma Seeks Up to $6.7 Million in Executive Bonuses

Purdue Pharma LP has asked a bankruptcy judge to approve bonuses for its top three executives worth up to $6.7 million, including up to $2.9 million for its CEO Craig Landau.

The OxyContin maker’s proposed incentive plans for the executives would pay them between $5.2 million to $6.7 million if they meet certain goals, Purdue said in a motion filed late Tuesday in the US Bankruptcy Court for the Southern District of New York.

The motion comes as Purdue waits on an appeals court to rule on its $6 billion opioid litigation settlement that would end its bankruptcy, which began ...